Redeye remains confident on the long-term case despite a major air pocket in the first quarter. Q1 saw a 20% drop in organic growth as demand was muted, particularly in Europe. Quarterly fluctiations are not unusual, but Tagmaster is still taking meassures to improve efficiency and lower its cost base. Redeye has revised its financial forecasts leading to a somewhat lower valuation.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/